TrialThe New England journal of medicine2017
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3,458 papers cite itlatest 60 shown
this paperpooled ittrialcites it